JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohr, R.
Right arrow Articles by Ramot, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohr, R.
Right arrow Articles by Ramot, B.

The Journal of Thoracic and Cardiovascular Surgery, Vol 92, 434-441, Copyright © 1986 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Effect of cardiac operation on platelets

R Mohr, M Golan, U Martinowitz, E Rosner, DA Goor and B Ramot

The effect of extracorporeal circulation on platelet count and size (mean platelet volume) was studied in 65 patients (nine bleeders and 56 nonbleeders). In addition to the above, in 20 of the patients platelet aggregation response to adenosine diphosphate, collagen, and ristocetin was measured. Platelet counts dropped postoperatively both in the bleeder and in the nonbleeder groups. The difference between them was not significant. However, the bleeders had a significantly lower mean platelet volume (7.7 +/- 0.84 versus 8.68 +/- 1.1 fl) and lower volume percentage of platelets in whole blood (0.075% +/- 0.02% versus 0.116% +/- 0.04%) (p less than 0.05) than the nonbleeders. None of the bleeders had a volume percentage of platelets in whole blood higher than 0.095%. All 20 patients studied for platelet functions had an abnormal postoperative aggregation response to adenosine diphosphate, collagen, and ristocetin. Three patterns of disturbed response to ristocetin were observed: grade I, delayed onset (14 patients); grade II, incomplete aggregation (five patients); and grade III, total lack of aggregation (one patient). All patients with delayed-onset response to ristocetin had a normal bleeding time, whereas the six patients with grade II and III responses had prolonged bleeding times and three of them had clinically significant bleeding. Factor VIII procoagulant activity, factor VIII-related antigen, factor VIII-ristocetin cofactor, and factor VIII two-dimensional electrophoresis were found normal, which suggests that the von Willebrand-like reaction to ristocetin observed in this study was caused by a defect in platelet membrane rather than by factor VIII changes.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al.
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Cianciolo, S. Stefoni, G. Donati, A. D. Pascalis, S. Iannelli, C. Manna, L. Coli, V. Bertuzzi, G. L. Manna, C. Raimondi, et al.
Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes
Nephrol. Dial. Transplant., June 1, 2001; 16(6): 1222 - 1229.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Klein, P.R. Keith, H.-P. Dauben, H.D. Schulte, H. Beckmann, G. Mayer, O. Elert, and E. Gams
Aprotinin counterbalances an increased risk of peri-operative haemorrhage in CABG patients pre-treated with Aspirin
Eur. J. Cardiothorac. Surg., October 1, 1999; 14(4): 360 - 366.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Kawahito, E. Kobayashi, H. Iwasa, Y. Misawa, and K. Fuse
Platelet aggregation during cardiopulmonary bypass evaluated by a laser light-scattering method
Ann. Thorac. Surg., January 1, 1999; 67(1): 79 - 84.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. H. Friesen, D. N. Campbell, D. R. Clarke, and M. A. Tornabene
Modified Ultrafiltration Attenuates Dilutional Coagulopathy in Pediatric Open Heart Operations
Ann. Thorac. Surg., December 1, 1997; 64(6): 1787 - 1789.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
A. Shinfeld, D. Zippel, J. Lavee, A. Lusky, E. Shinar, N. Savion, and R. Mohr
Aprotinin Improves Hemostasis After Cardiopulmonary Bypass Better Than Single-Donor Platelet Concentrate
Ann. Thorac. Surg., April 1, 1995; 59(4): 872 - 876.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
R. G. H. Speekenbrink, A. B. A. Vonk, C. R. H. Wildevuur, and L. Eijsman
Hemostatic Efficacy of Dipyridamole, Tranexamic Acid, and Aprotinin in Coronary Bypass Grafting
Ann. Thorac. Surg., February 1, 1995; 59(2): 438 - 442.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. M. Murkin, J. Lux, N. A. Shannon, G. M. Guiraudon, A. H. Menkis, F. N. McKenzie, and R. J. Novick
Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations
J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 554 - 561.
[Abstract] [Full Text]


Home page
PerfusionHome page
C. Dellora, P. Minola, and F. Parodi
C1-esterase inhibitor following cardiopulmonary bypass: evaluation of coagulation parameters - a preliminary report
Perfusion, July 1, 1992; 7(3): 195 - 199.
[Abstract] [PDF]


Home page
PerfusionHome page
P. Kesteven
Haemostatic changes during cardiopulmonary bypass
Perfusion, January 1, 1990; 5(1_suppl): 9 - 19.
[PDF]


Home page
PerfusionHome page
T. Spyt, N. Weerasena, W. Bain, G. Lowe, and A. Rumley
The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double-blind trial I
Perfusion, January 1, 1990; 5(1_suppl): 57 - 61.
[Abstract] [PDF]


Home page
PerfusionHome page
M. Sellman, T. Ivert, M. Blomback, and B. Semb
Haematological effects of a depth absorption arterial line filter during extracorporeal circulation
Perfusion, October 1, 1989; 4(4): 255 - 264.
[Abstract] [PDF]


Home page
PerfusionHome page
D. He and L. Hou
Effects of high dose ascorbic acid on haemostasis during and after cardiopulmonary bypass
Perfusion, October 1, 1988; 3(4): 281 - 286.
[Abstract] [PDF]


Home page
PerfusionHome page
B. P Bidstrup
Review article : Blood conservation in cardiac surgery: can drugs help?
Perfusion, July 1, 1988; 3(3): 171 - 177.
[PDF]


Home page
PerfusionHome page
T. Spyt, D. Wheatley, I. Walker, J. Davidson, K. MacArthur, and W. Martin
Placebo-controlled study of Iloprost (ZK 36374) in cardiopulmonary bypass surgery
Perfusion, July 1, 1988; 3(3): 179 - 186.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1986 by The American Association for Thoracic Surgery.